Hidradenitis Suppurativa

Aquaporins in Inflammatory Skin Diseases

Aquaporins are involved in the normal physiology of the skin, and the dysregulation of aquaporins is implicated in different skin disorders, serving as potential therapeutic targets. Aquaporins (AQPs) are membrane channel proteins that allow the movement of small neutral solutes and water, playing an important role in the skin’s barrier function. The altered skin barrier...

Inflammation, Poverty Have Synergistic Effect on Mortality

Individuals with elevated C-reactive protein at 1.0 mg/dL and poverty had a greater risk for 15-year all-cause mortality There is a potential synergistic effect for inflammation and living in poverty with increased mortality risk for adults, according to a study published online Jan. 16 in Frontiers in Medicine. Arch G. Mainous III, Ph.D., from the University...

Laser Therapy, Microneedling, and Chemical Peels for Skin of Color

As the aesthetics industry continues to grow, clinicians must educate themselves regarding appropriate treatments and protocols for patients with skin of color to prevent adverse reactions. There is a lack of information for Fitzpatrick skin types IV–VI, and increasing knowledge and skills is imperative for safe and effective treatments. With exponential growth in the aesthetics...

What Are the Most Common Skin Conditions Affecting African Americans?

Medical conditions impact everyone differently. Genetics, biology, and many other factors all come together to determine how a body will deal with a condition and, as a result, how serious the condition will be. Because of this, skin conditions are found at different incidence rates in different groups of people. This means the skin conditions...

Sexual, Gender Minorities With Chronic Skin Diseases More Likely to Face Barriers to Care

Cost and noncost barriers more likely for sexual and gender-minority patients with chronic inflammatory skin diseases Sexual and gender-minority (SGM) patients with chronic inflammatory skin diseases (CISDs) are more likely to experience cost and noncost barriers to care, according to a study published online Sept. 27 in JAMA Dermatology. Michael R. Nock, from the Yale School...

IL4-IL13 Inflammatory Pathway Inhibition

Dupilumab primarily acts on the IL13 expression of the MSCs in individuals with AD, which can improve the signs and symptoms of the disorder. Atopic dermatitis (AD) is an inflammatory skin disease, which appears during early childhood in 15–30% of cases, and usually resolves before the onset of puberty. However, more than 50% of the...
<<
  • 1
  • 2
>>

Categories

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.